Dianthus Therapeutics | MGTA - Рыночная капитализация





Рыночная капитализация Изменить Дата
Akebia Therapeutics USD 427M 297M 2025-12
Alaunos Therapeutics USD 7M 2M 2026-03
Avita Medical AUD 105.47M 35.32M 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 2.71B 1.87B 2026-07
Divis Laboratories Ltd INR 1.58T 118.27B 2026-03
IQVIA Holdings USD 28.63B 9.76B 2026-03
Kangmei Pharma CNY 24.48B 3.45B 2026-03
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Moderna USD 20.15B 8.53B 2026-03
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Organigram Holdings CAD 136.51M 115.96M 2026-07
Organon & Co USD 3.47B 1.9B 2026-07
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.57B 225M 2026-03
Qiagen NV USD 8.27B 1.62B 2026-03
Revvity USD 9.94B 1.03B 2026-03
Sartorius EUR 14.25B 2.16B 2026-03
Tectonic Therapeutic USD 510M 70M 2026-07
Viatris USD 15.73B 1.39B 2026-03
Xeris Pharmaceuticals USD 1.11B 112M 2026-07
Zealand Pharma A/S 33.35B 448.34M 2025-12